Anticoagulation Endpoints With Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real-World Setting: A Proposal for a New Pharmacogenetic Dosing Approach-Reference-Cited by-同舟云学术

Anticoagulation Endpoints With Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real-World Setting: A Proposal for a New Pharmacogenetic Dosing Approach

Published:2016-12-29 Issue:5 Volume:101 Page:675-683
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Arwood MJ¹²,Deng J³,Drozda K⁴,Pugach O⁵,Nutescu EA⁶⁷⁸,Schmidt S³,Duarte JD¹²,Cavallari LH¹²

Affiliation:

1. Department of Pharmacotherapy and Translational Research; University of Florida; Gainesville Florida USA

2. Center for Pharmacogenomics; University of Florida; Gainesville Florida USA

3. Center for Pharmacometrics and Systems Pharmacology; University of Florida at Lake Nona; Orlando Florida USA

4. Genomics and Targeted Therapy, Office of Clinical Pharmacology, US Food and Drug Administration; Silver Spring Maryland USA

5. Institute for Health Research and Policy; University of Illinois at Chicago; Chicago Illinois USA

6. Personalized Medicine Program; University of Illinois at Chicago; Chicago Illinois USA

7. Department of Pharmacy Systems; Outcomes and Policy, University of Illinois at Chicago; Chicago Illinois USA

8. Center for Pharmacoepidemiology and Pharmacoeconomic Research; University of Illinois at Chicago; Chicago Illinois USA

Funder

NIH/NIGMS

NIH/NHLBI

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.558/fullpdf

Reference45 articles.

1. National trends in ambulatory oral anticoagulant use;Barnes;Am J Med.,2015

2. Patterns of initiation of oral anticoagulants in patients with atrial fibrillation - quality and cost implications;Desai;Am J Med.,2014

3. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis. 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;Guyatt;Chest,2012

4. Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation;Steinberg;J Am Heart Assoc,2013

5. Urgent need to measure effects of direct oral anticoagulants;Weitz;Circulation,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging QSP Models for MIPD: A Case Study for Warfarin/INR;Clinical Pharmacology & Therapeutics;2024-04-24

2. Cardiovascular pharmacogenomics – Molecular basis of protective and adverse drug response;Genomic and Molecular Cardiovascular Medicine;2024

3. Comparison of Maintenance Dose Predictions by Warfarin Dosing Algorithms Based on Chinese and Western Patients;The Journal of Clinical Pharmacology;2023-01-12

4. Cardiovascular precision medicine – A pharmacogenomic perspective;Cambridge Prisms: Precision Medicine;2023

5. Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report;Thrombosis Journal;2022-10-27